Akero Therapeutics, Inc.
AKRODelisted Dec 9, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001744659
Akero Therapeutics, Inc. was delisted on Dec 9, 2025; its insiders filed their last Form 4 on Dec 9, 2025; 265 institutions reported holding it in 13F filings for Q3 2025, worth $4.34B in total; no superinvestor held it.
Q3 2021 vs. Q2 2021
How the institutions holding Akero Therapeutics, Inc. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Q3 2021 | Change |
|---|---|---|---|
| Holders | 97 | 103 | +6 |
| Shares | 27.7M | 28.0M | +246.2K (+0.9%) |
| Value | $684.2M | $626.0M | −$58.2M (−8.5%) |
New holders (9)
Institutions that held Akero Therapeutics, Inc. at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Kore Private Wealth LLC | 305,376 | $6.83M | 0.72% |
| Karp Capital Management Corp | 37,005 | $827.0K | 0.12% |
| ACT Capital Management, LLC | 23,000 | $514.0K | 0.27% |
| Martingale Asset Management L P | 22,911 | $513.0K | 0.01% |
| Stansberry Asset Management, LLC | 21,883 | $489.0K | 0.10% |
| Macquarie Group Ltd | 4,357 | $97.0K | 0.00% |
| First Mercantile Trust Co | 2,030 | $45.0K | 0.01% |
| Captrust Financial Advisors | 141 | $3.00K | 0.00% |
| Signaturefd, LLC | 48 | $1.00K | 0.00% |
Sold out (3)
Institutions that held Akero Therapeutics, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Silverarc Capital Management, LLC | 33,028 | $819.0K |
| Bridgefront Capital, LLC | 12,099 | $300.0K |
| Allstate Corp | 8,384 | $208.0K |